You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CALCIUM GLUCONATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for calcium gluconate and what is the scope of freedom to operate?

Calcium gluconate is the generic ingredient in two branded drugs marketed by Amneal, B Braun Medical Inc, Fresenius Kabi Usa, Nivagen Pharms Inc, Somerset, and Hq Spclt Pharma, and is included in seven NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for calcium gluconate. Eleven suppliers are listed for this compound.

Drug Prices for CALCIUM GLUCONATE

See drug prices for CALCIUM GLUCONATE

Recent Clinical Trials for CALCIUM GLUCONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ascension Genesys HospitalPhase 2
Aurora Health CarePhase 4
First Affiliated Hospital Xi'an Jiaotong UniversityN/A

See all CALCIUM GLUCONATE clinical trials

Pharmacology for CALCIUM GLUCONATE

US Patents and Regulatory Information for CALCIUM GLUCONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 217174-001 Sep 5, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 217174-002 Sep 5, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa CALCIUM GLUCONATE calcium gluconate SOLUTION;INTRAVENOUS 208418-003 Jun 15, 2017 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-001 Oct 29, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Amneal CALCIUM GLUCONATE calcium gluconate SOLUTION;INTRAVENOUS 216611-001 May 10, 2024 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.